# Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer

> **NCT00288444** · PHASE1 · TERMINATED · sponsor: **Emory University** · enrollment: 38 (actual)

## Conditions studied

- Lung Cancer
- Soft Tissue Sarcoma
- Colorectal Carcinoma
- Breast Cancer
- Prostate Cancer

## Interventions

- **DRUG:** Lonafarnib
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00288444
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2009-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288444, "Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00288444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*